Energy News  
EPIDEMICS
Brazil's Lula visits anti-retroviral plant in Mozambique

by Staff Writers
Maputo (AFP) Nov 10, 2010
Brazilian President Luiz Inacio Lula da Silva on Wednesday visited what is set to become Africa's first public factory for anti-HIV drugs, closing his last official visit to Africa with a focus on the fight against AIDS.

Lula, who hands over the reins to protege Dilma Rousseff on January 1, called the new anti-retroviral (ARV) drug factory in Mozambique a "revolution" for Africa's efforts to control the disease.

"The fact that we are building the African continent's first factory to produce anti-AIDS drugs can be seen as a revolution," Lula said at the plant on the outskirts of the Mozambican capital Maputo, a stop en route to this week's G20 summit in Seoul.

The 25-million-dollar (18.1-million-euro) factory is being built with the help of 21 million dollars in aid from Brazil and is expected to begin packaging Brazilian-made pills by the end of 2011, producing its own pills by the end of 2012.

Lula, who proposed the idea on a state visit to Mozambique during his first year in office in 2003, toured the site of the new facility and inspected its first piece of equipment, a packaging machine donated by Brazil.

He said he hopes to return to inaugurate the factory when it is complete.

"We have a new president who's going to take over in Brazil on January 1, so I want to be here as a guest together with (Mozambican) President (Armando) Guebuza when Mozambique's anti-retroviral factory produces its first pill."

Mozambique has more than 2.5 million people living with HIV -- nearly 12 percent of the population -- but just 210,000 take ARVs, according to the Mozambican health ministry.

The country depends on foreign aid to finance 80 percent of its HIV medication.

The factory aims to help Mozambique increase the availability and affordability of ARVs, following in Brazil's footsteps in the fight against AIDS.

Brazil famously offers free ARV treatment to every HIV-positive citizen, a programme that sparked controversy when it was announced in 1996 because of concerns about drug resistance and violation of pharmaceutical copyrights.

But it has since been praised as a model for the developing world. The World Bank estimates the free medicine saved more than half a million lives.

While several private laboratories in Africa have ventured into small-scale ARV production, the Mozambican factory will be the first public facility on the continent to produce the drugs.

"We have been confronting one of the worst public health problems using only preventive methods," Health Minister Alexandre Manguele told AFP.

Manguele said he estimates that only half the Mozambicans who need ARV treatment are receiving it.

"With the launch of the factory, we'll produce the medicine we need here. We'll be able to extend people's lives and turn this deadly disease into a chronic illness that we're able to treat," he said.

The factory aims to produce five different types of ARVs for a total output of 226 million pills a year. Officials said it will also produce 145 million pills of other types, including antibiotics.



Share This Article With Planet Earth
del.icio.usdel.icio.us DiggDigg RedditReddit
YahooMyWebYahooMyWeb GoogleGoogle FacebookFacebook



Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


EPIDEMICS
Haiti capital battles arrival of cholera
Port-Au-Prince (AFP) Nov 10, 2010
Aid groups fought Wednesday to halt the spread of cholera in Haiti's teeming capital, where makeshift camps crammed with earthquake survivors are ripe ground for the epidemic to take hold. The outbreak erupted in the Artibonite River valley in central Haiti in mid-October and initially seemed to have been contained, but the toll from the chronic diarrheal disease has since soared to 643 dead ... read more







EPIDEMICS
Go For Getz And A South Pole Flyover

FCC investigating Google 'Street View' data harvest

NASA Study Quantifies Role Of Melt In Loss Of Old Arctic Sea Ice

Nicaragua, Costa Rica tense over map 'war'

EPIDEMICS
Lockheed Martin Delivers Key GPS III Test Hardware Ahead of Schedule

Few Americans using location-based services: Pew study

GPS maker Garmin hanging up on smartphones

Savi Challenges You To Imagine The Best Wireless Applications

EPIDEMICS
New Discoveries Concerning Pre-Columbian Settlements In The Amazon

Brazil mulls land auction to beat logging

Footage shows land clearing threatens Indonesia tigers: WWF

Litter collected, trees planted for global climate campaign

EPIDEMICS
OriginOil Achieves Hydrogen Production Comparable To Photovoltaics

Growing Sorghum For Biofuel

Pennycress Could Go From Nuisance Weed To New Source Of Biofuel

Grasses Have Potential As Alternate Ethanol Crop

EPIDEMICS
Johnson Controls To Install PV Arrays At 73 Utah Schools

Skyline Solar Awarded Two Additional Green Patents From The USPTO

RICOH USA Goes Solar

iSuppli Boosts 2010 Solar Installation Forecast

EPIDEMICS
Global Warming Reduces Available Wind Energy

South Korea plans offshore wind project

Buoyant Times Ahead For Offshore Resource Assessments

Suzlon eyes China's wind power market

EPIDEMICS
Twelve killed in China coal mine flood: state media

Colombia coal mining gets a timely boost

China mines to beef up safety after Chile rescue: official

China mine death toll hits 31 as anger rises over rescue

EPIDEMICS
Pet boom has Shanghai mulling one-dog policy

British PM, in China, urges G20 cooperation, more freedoms

China jails milk scandal activist: lawyer

Lawyer linked to Nobel winner says barred from leaving China


The content herein, unless otherwise known to be public domain, are Copyright 1995-2010 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement